Gene · 347
APOD: apolipoprotein D
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. APOD: apolipoprotein D. Genes, record 347. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/347
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| P05090 | Apolipoprotein D | 189 | 2 | Ensembl, GeneID, HGNC |
Source UniProt
Patents166
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| JP 2026004568 A | 2026-01-14 | 37674 | P05090 | Espacenet |
| WO 2025259600 A2 | 2025-12-18 | 86 | P05090 | Espacenet |
| EP 4650780 A2 | 2025-11-19 | 6951 | P05090 | Espacenet |
| JP 2025147176 A | 2025-10-06 | 974 | P05090 | Espacenet |
| JP 2025529142 A | 2025-09-04 | 5508 | P05090 | Espacenet |
| US 12371689 B2 | 2025-07-29 | 5508 | P05090 | Espacenet |
| EP 4587839 A2 | 2025-07-23 | 29 | P05090 | Espacenet |
| JP 2025517970 A | 2025-06-12 | 6951 | P05090 | Espacenet |
| JP 2025062604 A | 2025-04-14 | 5727 | P05090 | Espacenet |
| JP 2025032204 A | 2025-03-11 | 24573 | P05090 | Espacenet |
1 to 10 of 166
See all 166 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants1,371
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | APOD papers | Newest fiscal year |
|---|---|---|---|
| P30DK017047 | Diabetes Research Center | 6 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 5 | 2025 |
| P30ES017885 | Michigan Center on Lifestage Environmental Exposures and Disease (M-LEEaD) | 5 | 2025 |
| P30DK035816 | Nutrition Obesity Research Center | 4 | 2025 |
| P01AG026276 | Antecedent Biomarkers for Alzheimer Disease: The Adult Children Study | 3 | 2025 |
| P30CA008748 | Cancer Center Support Grant | 3 | 2025 |
| P30CA068485 | Cancer Center Support Grant | 3 | 2025 |
| P30EY000331 | Vision Research Core at UCLA | 3 | 2025 |
| P30EY005722 | Center Core Grant for Vision Research | 3 | 2025 |
| P50CA097186 | The Pacific Northwest Prostate Cancer SPORE | 3 | 2025 |
1 to 10 of 1,371Source NIH's project files
See all 1,371 nih grantsPapers2,410
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
Unraveling tumor cell heterogeneity and epithelial-mesenchymal plasticity in gastric adenocarcinoma: an integrative multi-omics framework evaluating PVR/CD155 as a tumor cell-intrinsic EMT-associated target. | Front Immunol | 2026 | 42769440 | PubTator, text mining | PubMed |
| A Photoaffinity Probe for S‑Guanylation Posttranslational Modification to Identify Its Interacting Proteins. | Arch Pharm (Weinheim) | 2026 | 42768936 | PubTator, text mining | PubMed |
| Identification and expression validation of key genes of Xiaozhengtongluo formula in the treatment of diabetic nephropathy by Mendelian randomization. | Funct Integr Genomics | 2026 | 42754788 | PubTator, text mining | PubMed |
| Host eicosanoid signals define a granuloma fibroblast population that coordinates mycobacterial containment. | Cell Host Microbe | 2026 | 42641606 | PubTator, text mining | PubMed |
| Sex-Associated Proteomic Signatures Persist Independent of Injury Severity and Shock Physiology in Acute Trauma. | Shock | 2026 | 42625553 | PubTator, text mining | PubMed |
| An integrative analysis of UFMylation-related genes reveals a prognostic signature and identifies GDF7 as a novel therapeutic target in gastric cancer. | Front Oncol | 2026 | 42577178 | PubTator, text mining | PubMed |
| Integrative Analysis of Steroid Metabolism-Based Molecular Subtypes Reveals Prognostic Subtypes and Therapeutic Implications in Gastric Cancer. | Cancer Inform | 2026 | 42571211 | PubTator, text mining | PubMed |
| Improved Apocrine-Pilosebaceous Unit Extraction Technique for the Treatment of Axillary Bromhidrosis. | Aesthetic Plast Surg | 2026 | 42521784 | PubTator, text mining | PubMed |
| Beneficial Changes in Apolipoprotein Concentrations After Bariatric Surgery in Obese Women. | Metabolites | 2026 | 42506447 | PubTator, text mining | PubMed |
| Integrated Proteogenomics and Single-Cell Transcriptomics Prioritize Putative Protective Plasma Proteins for Hidradenitis Suppurativa. | Exp Dermatol | 2026 | 42499219 | PubTator, text mining | PubMed |
1 to 10 of 2,410
See all 2,410 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/347
GET https://conductscience.org/api/genes/v1/347/patents?page=2